3 ratings / 5 average

Remission in Inflammatory Arthritis: Past, Present, and Future

Benazir Saleem, MD, and Paul Emery, MD

Remission is the aim of treatment for patients with rheumatoid arthritis (RA). Early treatment with tight control of inflammation and the use of targeted biological therapies has greatly increased remission rates in recent years. This article reviews the remarkable changes in the management of RA patients that have taken place over the last 30 years, with a switch from a cautious slow escalation of therapy to the use of earlier aggressive treatment allowing words such as “remission” and “cure” to become a reality in clinical practice. Int J Adv Rheumatol 2011;9(3):77–83.

Return to top

RELATED ARTICLES

Anti-Citrullinated Protein Antibodies as a Risk Factor for Rheumatoid Arthritis
Diane van der Woude, MD, and Tom WJ Huizinga, MD, PhD
International Journal of Advances in Rheumatology
The Economics of Rheumatoid Arthritis Management
Daniel H Solomon, MD, MPH1, and Arthur F Kavanaugh, MD2
International Journal of Advances in Rheumatology
A Question and Answer Approach to Rheumatoid Arthritis Disease Activity
Daniel Aletaha, MD, and Josef Smolen, MD
International Journal of Advances in Rheumatology
Cardiovascular Risk Factors in Rheumatoid Arthritis
Hilal Maradit Kremers, MD, MSc, Cynthia S Crowson, MS, and Sherine E Gabriel, MD, MSc
CML Rheumatology
Serum Autoantibodies in Rheumatoid Arthritis
Raimon Sanmartí, MD, Maria Victoria Hernández, MD, José A Gómez-Puerta, MD, Eduard Graell, MD, and Juan D Cañete, MD, PhD
International Journal of Advances in Rheumatology
Cardiovascular Aspects of Rheumatoid Arthritis
Michael T Nurmohamed, MD, PhD
International Journal of Advances in Rheumatology

LATEST ARTICLES